• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

烟雾病的长期预后

Long-Term Outcome of Moyamoya Disease.

作者信息

Birkeland Peter, Hansen Victoria, Tharmabalan Vinosha, Lauritsen Jens, Nielsen Troels, Truelsen Thomas, Rosenbaum Sverre, von Weitzel-Mudersbach Paul

机构信息

Department of Neurosurgery, Copenhagen University Hospital, Copenhagen, Denmark.

Department of Neurology, Aalborg University Hospital, Aalborg, Denmark.

出版信息

Acta Neurochir Suppl. 2025;136:93-97. doi: 10.1007/978-3-031-89844-0_11.

DOI:10.1007/978-3-031-89844-0_11
PMID:40632258
Abstract

Moyamoya disease (MMD) is considered to run a progressive course, but little is known about its long-term outcomes. We conducted a structured phone interview to assess outcomes in a mixed cohort of conservatively and surgically treated patients a median of 9 years and up to 27 years after a diagnosis of MMD. We found that 60% of patients had a favorable outcome (modified Rankin Scale score <3), with only 16% of adult patients working full time. We conclude that MMD considerably impacts daily life in a substantial number of those affected, with only a minority able to provide for themselves.

摘要

烟雾病(MMD)被认为呈进行性病程,但对其长期预后知之甚少。我们进行了一次结构化电话访谈,以评估一组经保守治疗和手术治疗的混合队列患者在诊断为烟雾病后中位9年至长达27年的预后情况。我们发现,60%的患者预后良好(改良Rankin量表评分<3),只有16%的成年患者全职工作。我们得出结论,烟雾病对大量患者的日常生活有相当大的影响,只有少数患者能够自给自足。

相似文献

1
Long-Term Outcome of Moyamoya Disease.烟雾病的长期预后
Acta Neurochir Suppl. 2025;136:93-97. doi: 10.1007/978-3-031-89844-0_11.
2
Incidence and Outcomes of Posterior Circulation Involvement in Moyamoya Disease.烟雾病后循环受累的发病率及预后
Stroke. 2024 May;55(5):1254-1260. doi: 10.1161/STROKEAHA.123.044693. Epub 2024 Apr 3.
3
OCTA changes of retinal microvessels and thickness in moyamoya disease.烟雾病患者视网膜微血管的光学相干断层扫描血管造影(OCTA)变化及视网膜厚度
Sci Rep. 2025 Jul 1;15(1):22143. doi: 10.1038/s41598-025-08501-5.
4
The Management of Symptomatic Moyamoya Disease in Pediatric Patients: A Systematic Review and Meta-Analysis.小儿症状性烟雾病的管理:一项系统评价和荟萃分析
Neurosurgery. 2024 Nov 14;97(1):65-81. doi: 10.1227/neu.0000000000003277.
5
Long-Term Outcomes in Patients With Hemorrhagic Moyamoya Disease Combined With Hypertension After Encephaloduroarteriosynangiosis.脑-硬脑膜-动脉血管融通术后出血型烟雾病合并高血压患者的长期预后
J Am Heart Assoc. 2025 Jun 17;14(12):e039054. doi: 10.1161/JAHA.124.039054. Epub 2025 Jun 16.
6
Efficacy and Safety of Combined Revascularization Surgery for Moyamoya Disease: Standard Procedure and Perioperative Management.烟雾病联合血运重建手术的疗效与安全性:标准手术流程及围手术期管理
Acta Neurochir Suppl. 2025;136:99-104. doi: 10.1007/978-3-031-89844-0_12.
7
3D exoscopic versus microscopic superficial temporal artery to middle cerebral artery bypass surgery for moyamoya disease - a comparative series.3D 外显式与显微镜下颞浅动脉-大脑中动脉搭桥术治疗烟雾病的对比系列研究。
Acta Neurochir (Wien). 2024 Jun 7;166(1):254. doi: 10.1007/s00701-024-06100-3.
8
Understanding external carotid artery collateralisation after cerebral revascularisation in moyamoya disease: insights from quantitative analysis.烟雾病脑血管重建术后颈外动脉侧支循环的认识:来自定量分析的见解
Stroke Vasc Neurol. 2025 Jun 30;10(3):371-378. doi: 10.1136/svn-2024-003336.
9
Withdrawal or continuation of cholinesterase inhibitors or memantine or both, in people with dementia.在痴呆症患者中,停用或继续使用胆碱酯酶抑制剂、美金刚或两者。
Cochrane Database Syst Rev. 2021 Feb 3;2(2):CD009081. doi: 10.1002/14651858.CD009081.pub2.
10
Association of retrograde bypass flow depth along cortical recipient arteries with revascularization outcomes in direct bypass surgery for Moyamoya disease.沿皮质受体动脉逆行旁路血流深度与直接旁路手术治疗烟雾病再血管化结局的关系。
Clin Neurol Neurosurg. 2024 Dec;247:108636. doi: 10.1016/j.clineuro.2024.108636. Epub 2024 Nov 13.

本文引用的文献

1
Moyamoya angiopathy: long-term follow-up study in a Finnish population.烟雾病:芬兰人群的长期随访研究。
J Neurol. 2019 Mar;266(3):574-581. doi: 10.1007/s00415-018-9154-7. Epub 2018 Dec 17.
2
The Danish National Patient Registry: a review of content, data quality, and research potential.丹麦国家患者登记处:内容、数据质量及研究潜力综述
Clin Epidemiol. 2015 Nov 17;7:449-90. doi: 10.2147/CLEP.S91125. eCollection 2015.
3
Moyamoya: defining current knowledge gaps.烟雾病:明确当前的知识空白。
Dev Med Child Neurol. 2015 Sep;57(9):786-7. doi: 10.1111/dmcn.12708. Epub 2015 Feb 13.
4
Effects of extracranial-intracranial bypass for patients with hemorrhagic moyamoya disease: results of the Japan Adult Moyamoya Trial.颅内外血管搭桥术治疗出血性烟雾病患者的效果:日本成人烟雾病试验结果。
Stroke. 2014 May;45(5):1415-21. doi: 10.1161/STROKEAHA.113.004386. Epub 2014 Mar 25.
5
Regional differences in incidence and patient characteristics of moyamoya disease: a systematic review.烟雾病发病和患者特征的地域差异:系统综述。
J Neurol Neurosurg Psychiatry. 2012 May;83(5):531-6. doi: 10.1136/jnnp-2011-301387. Epub 2012 Feb 29.
6
Simplified modified rankin scale questionnaire: reproducibility over the telephone and validation with quality of life.简化后的改良 Rankin 量表问卷:电话回访的可重复性和与生活质量的验证。
Stroke. 2011 Aug;42(8):2276-9. doi: 10.1161/STROKEAHA.111.613273. Epub 2011 Jun 16.
7
Moyamoya disease and moyamoya syndrome.烟雾病和烟雾综合征。
N Engl J Med. 2009 Mar 19;360(12):1226-37. doi: 10.1056/NEJMra0804622.
8
Moyamoya disease: current concepts and future perspectives.烟雾病:当前概念与未来展望。
Lancet Neurol. 2008 Nov;7(11):1056-66. doi: 10.1016/S1474-4422(08)70240-0.
9
Novel epidemiological features of moyamoya disease.烟雾病的新型流行病学特征。
J Neurol Neurosurg Psychiatry. 2008 Aug;79(8):900-4. doi: 10.1136/jnnp.2007.130666. Epub 2007 Dec 12.
10
Cerebrovascular "moyamoya" disease. Disease showing abnormal net-like vessels in base of brain.脑血管“烟雾病”。该病表现为脑底部出现异常的网状血管。
Arch Neurol. 1969 Mar;20(3):288-99. doi: 10.1001/archneur.1969.00480090076012.